share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  04/25 06:05

Moomoo AI 已提取核心信息

The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034615 and file number 333-272749, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant step for 180 Life Sciences Corp., indicating that the regulatory body has reviewed and accepted the company's submission.
The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034615 and file number 333-272749, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant step for 180 Life Sciences Corp., indicating that the regulatory body has reviewed and accepted the company's submission.
美国证券交易委员会(SEC)宣布,180 Life Sciences Corp. '的提交已于 2024 年 4 月 24 日生效。该提交的材料以入库号0001213900-24-034615和文件编号333-272749进行识别,归类为提交类型 POS AM。美国证券交易委员会发布的这份生效通知对180生命科学公司来说是重要的一步,这表明监管机构已经审查并接受了该公司提交的文件。
美国证券交易委员会(SEC)宣布,180 Life Sciences Corp. '的提交已于 2024 年 4 月 24 日生效。该提交的材料以入库号0001213900-24-034615和文件编号333-272749进行识别,归类为提交类型 POS AM。美国证券交易委员会发布的这份生效通知对180生命科学公司来说是重要的一步,这表明监管机构已经审查并接受了该公司提交的文件。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息